Cancer BiologybioRxivPreprint
DNA-PK enforces the S/G2 checkpoint in ATM-deficient cells to limit ATR inhibitor efficacy
Timothy B. Branigan, Roshen Alharthi, Bose S. Kochupurakkal…·Geoffrey Ira Shapiro
This study shows DNA-PK enforces the S/G2 checkpoint in ATM-deficient cells, reducing ATR inhibitor efficacy, and suggests combining ATR and DNA-PK inhibition could enhance treatment in such cancers.
DOI 10.64898/2026.10.25.761677